In a large multicenter cohort of blunt trauma patients, 24% had rib fractures and two thirds of these were missed by plain films.
Computed tomography (CT) is more sensitive than plain films for rib fractures, but by how much? To answer this question, investigators conducted a planned secondary analysis of two prospective cohort studies of blunt trauma patients enrolled in the National Emergency X-Radiography Utilization Study. The investigators also compared mortality between patients with first or second rib fractures and those with fractures of other ribs.
Of 8661 patients who had both a chest CT scan and a chest x-ray performed in the emergency department, 24% had rib fractures, and 66% of fractures were seen only on CT scan. Patients with first or second rib fractures had significantly higher mortality than those with other rib fractures (7% vs. 4%), and were signi…
Reviewing Author
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals